Filter by: patients
Home > Community Treatment Reports and Side Effects > Entacapone Treatment Report
What is Entacapone?

Entacapone is an inhibitor of catechol-O-methyltransferase (COMT) and is indicated as an adjunct treatment for patients taking levodopa and carbidopa for Parkinson’s Disease who experience the signs and symptoms of end-of-dose “wearing-off”.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Parkinson's Disease 206 27 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Increase effect of another treatment 39 11 Efficacy_major Efficacy_moderate Efficacy_slight Efficacy_none Efficacy_cant_tell
Wearing off effect 16 5 Efficacy_major Efficacy_moderate
Other 6 3 Efficacy_major Efficacy_moderate
Stiffness/Spasticity 6 1 Efficacy_cant_tell
to extend effect of Sinimet 5 2 Efficacy_moderate Efficacy_cant_tell

See all 237 patients currently taking Entacapone

Mouse over the table for more information

Reported Dosages

Frequently reported dosages based on patients currently taking Entacapone. See all 19 dosages ►

  daily 200 mg daily 300 mg daily 400 mg daily 600 mg daily 800 mg daily 1,000 mg daily 1,200 mg daily 1,400 mg daily 1,600 mg daily
  5 Number of Patients: 5 31 Number of Patients: 31 5 Number of Patients: 5 19 Number of Patients: 19 52 Number of Patients: 52 66 Number of Patients: 66 30 Number of Patients: 30 11 Number of Patients: 11 5 Number of Patients: 5 3 Number of Patients: 3  

Reported Stop Reasons

Why Patients Stopped Taking Entacapone (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work 21   Did not seem to work: 30%
Side effects too severe 21   Side effects too severe: 30%
Doctor's advice 17   Doctor's advice: 25%
Other 12   Other: 17%
Expense 6   Expense: 9%
Not indicated 2   Not indicated: 3%
Course of treatment ended 2   Course of treatment ended: 3%
Personal research 1   Personal research: 1%

See all 63 patients who’ve stopped taking Entacapone

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Entacapone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0

Stopped Taking Entacapone

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Entacapone

Always
 37 76%
Usually
 12 24%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Entacapone

Very
 3 6%
Somewhat
 8 16%
A little
 7 14%
Not at all
 31 63%

Cost

Paid out of pocket

Cost of Entacapone

$200+
 4 11%
$100-199
 3 9%
$50-99
 1 3%
$25-49
 12 34%
< $25
 15 43%

See more information, including instructions, precautions, side effects, and interactions.

Report created on May 27, 2012.